C
Cheng-fu Cao
Researcher at Peking University
Publications - 8
Citations - 10
Cheng-fu Cao is an academic researcher from Peking University. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 1, co-authored 4 publications receiving 2 citations.
Papers
More filters
Journal ArticleDOI
Comparison of bailout and planned rotational atherectomy for severe coronary calcified lesions.
TL;DR: For severe coronary artery calcification, although planned RA did not improved the long term prognosis compared with bailout RA, but it can improve the immediate procedural success rate, reduce the incidence of complications, the procedure time and the volume of contrast.
Journal ArticleDOI
Comparison of optical coherence tomography-guided and intravascular ultrasound-guided rotational atherectomy for calcified coronary lesions.
Wei-Li Teng,Qi Li,Yu-liang Ma,Cheng-fu Cao,Jian Liu,Hong Zhao,Ming-yu Lu,Chang Hou,Wei-min Wang +8 more
TL;DR: In this article, the effect and outcomes of OCT-guided rotational atherectomy (RA) with intravascular ultrasound (IVUS)-guided RA in the treatment of calcified coronary lesions were compared.
Journal ArticleDOI
Correction: Left ventricular function and coronary microcirculation in patients with mild reduced ejection fraction after STEMI
Journal ArticleDOI
Left ventricular function and coronary microcirculation in patients with mild reduced ejection fraction after STEMI
Yu-liang Ma,Lan Wang,Wenying Jin,Tiangang Zhu,Jian Liu,Hong Zhao,Jing Wang,Ming Lu,Cheng-fu Cao,Bo Jiang +9 more
TL;DR: In this article , the authors evaluated left ventricular (LV) function and coronary microcirculation in patients with mildly reduced ejection fraction after acute ST-segment elevation myocardial infarction (STEMI).
Journal ArticleDOI
Long-term Clinical Outcomes of Coronary Rotational Atherectomy for Specific Indications
TL;DR: In this article , the authors compared the long-term outcomes between rotational atherectomy (RA) for specific indications and on-label use of RA for severely calcified coronary lesions.